Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients
This study has been completed.
Sponsor:
Oncothyreon Canada Inc.
Information provided by:
Oncothyreon Canada Inc.
ClinicalTrials.gov Identifier:
NCT00046371
First received: September 27, 2002
Last updated: January 22, 2008
Last verified: January 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | August 2005 |
| Estimated Primary Completion Date: | No date given |